Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (235)	10/7/2002 7:31:09 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 362

Seems to back what some of us have been saying all along, that the company was ilo, and that the rest was bait and switch fodder. But then, with a MC of $40M, the damage is done. This is really low. Many CEOs have derived wealth from a biotech without ever having built a business, but this is a new low IMO. (exception with respect to my stance was pivanex, which intrigued me. but they let it lay fallow as long as ilo worked to suck people in, IMO.) Pedigree, we all need to be aware of pedigree. That's why I've proposed that this company was taking garbage forward, to give the appearance of a pipe where little existed. From an old prospectus......... LINDSAY A. ROSENWALD, M.D., is a co-founder of the Company and has served as a director of the Company since March 1993. Dr. Rosenwald co-founded Interneuron Pharmaceuticals, Inc. and has served as its Chairman since February 1989. Dr. Rosenwald has been the Chairman and President of The Castle Group, Ltd., a New York medical venture capital firm ("Castle"), since October 1991, and the Chairman and President of Paramount Capital, Inc., an investment banking firm, since February 1992. Prior thereto, Dr. Rosenwald was a Managing Director, Corporate Finance at Blair. Dr. Rosenwald also is a director of BioCryst Pharmaceuticals, Inc., Sparta Pharmaceuticals, Inc., Atlantic Pharmaceuticals, Inc., Xenometrix, Inc., Avigen, Inc., Neose Technologies, Inc., VimRX Pharmaceuticals, Inc., and Ansan and is Chairman of the Board or a director of a number of privately held companies founded by Castle in the biotechnology or pharmaceutical fields. Message 4663080